Add To Watchlist

IMCLONE-CHAIRMAN-CARL-ICAHN

The Wire

Eli Lilly to buy ImClone for more than $6B

Oct 6 - By Tom Murphy, AP Business Writer

Eli Lilly & Co.'s winning bid of more than $6 billion for cancer drugmaker ImClone Systems means a billion-dollar payday for former rival bidder Bristol-Myers and vindication for corporate raider and ImClone Chairman Carl Icahn.

, , , , , ,
0
0 Comments
The Vine
This area needs news. Click here to seed the vine